E. Naparstek

Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma

A. Nagler, L. Deutsch, O. Paltiel, 2003, Bone Marrow Transplantation.

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

A. Nagler, D. Engelhard, S. Slavin, 2001, Bone Marrow Transplantation.

Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.

A. Nagler, J. Kapelushnik, S. Slavin, 1995, Experimental hematology.

Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.

A. Nagler, A. Chetrit, S. Elad, 1996, Transplantation.

The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?

S. Slavin, R. Or, L. Weiss, 1990, Bone marrow transplantation.

Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study.

A. Nagler, A. Simhon, D. Engelhard, 1995, Bone marrow transplantation.